GlaxoSmithKline Pharmaceuticals Limited Share Price NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,626.40 INR | -0.24% |
|
+4.78% | +6.18% |
| Market Cap | 445B 4.65B 4.08B 3.81B 3.5B 6.55B 6.71B 45.19B 17.67B 220B 17.45B 17.07B 761B | P/E 2027 * |
38.7x | P/E 2028 * | 34.4x |
|---|---|---|---|---|---|
| Enterprise Value | 445B 4.65B 4.08B 3.81B 3.5B 6.55B 6.71B 45.19B 17.67B 220B 17.45B 17.07B 761B | EV / Sales 2027 * |
10.6x | EV / Sales 2028 * | 9.57x |
| Free-Float |
24.37% | Yield 2027 * |
1.12% | Yield 2028 * | 1.12% |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | -0.24% | ||
| 1 week | +4.78% | ||
| Current month | +7.19% | ||
| 1 month | +11.53% | ||
| 3 months | +8.97% | ||
| 6 months | +7.90% | ||
| Current year | +6.18% |
| 1 week | 2,455 |  | 2,670 |
| 1 month | 2,335.4 | | 2,670 |
| Current year | 2,088.1 | | 2,719.8 |
| 1 year | 2,088.1 | | 3,200 |
| 3 years | 1,385.05 | | 3,515.7 |
| 5 years | 1,227 | | 3,515.7 |
| 10 years | 962.65 | | 3,515.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 30/11/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 31/03/2026 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 07/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Subesh Williams
BRD | Director/Board Member | 64 | 06/04/2017 |
Renu Sud Karnad
CHM | Chairman | 73 | 31/03/2019 |
| Director/Board Member | 59 | 17/05/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.24% | +4.78% | - | - | 4.68B | |
| -0.50% | +4.89% | +59.89% | +168.38% | 1,089B | |
| -0.37% | +4.35% | +58.68% | +59.23% | 643B | |
| +0.47% | +5.22% | +39.38% | +78.18% | 465B | |
| -1.69% | +8.81% | +39.38% | +33.67% | 359B | |
| -0.51% | +3.51% | +36.97% | +42.46% | 303B | |
| +1.50% | +3.40% | +17.71% | +17.41% | 267B | |
| +0.79% | +5.81% | -2.55% | -38.10% | 226B | |
| -1.01% | +6.40% | +28.30% | +66.33% | 212B | |
| -0.23% | +3.03% | +17.56% | +76.37% | 167B | |
| Average | -0.08% | +5.07% | +32.81% | +55.99% | 414.57B | |
| Weighted average by Cap. | -0.07% | +5.14% | +42.80% | +81.89% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 41.99B 438M 385M 360M 330M 618M 633M 4.26B 1.67B 20.78B 1.65B 1.61B 71.83B | 46.49B 485M 426M 398M 365M 684M 701M 4.72B 1.85B 23B 1.82B 1.78B 79.53B |
| Net income | 11.42B 119M 105M 97.77M 89.72M 168M 172M 1.16B 453M 5.65B 448M 438M 19.53B | 12.54B 131M 115M 107M 98.57M 185M 189M 1.27B 498M 6.21B 492M 481M 21.46B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/07/26 | ₹2,626.40 | -0.24% | 59,537 |
| 28/07/26 | ₹2,632.60 | +3.19% | 101,759 |
| 27/07/26 | ₹2,551.20 | +1.47% | 67,921 |
| 24/07/26 | ₹2,514.30 | +0.77% | 63,793 |
| 23/07/26 | ₹2,495.00 | -2.26% | 60,968 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
